Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3592

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3592 9)

Label for Sildenafil 25 mg film-coated tablets, package of 90 tablets, manufactured by NuCare Pharmaceuticals, Inc. The label includes dosage form, strength, NDC 68071-3592-9, manufacturer details, a barcode, and a warning to keep out of reach of children. Storage instructions specify controlled temperature 68-77°F.*

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

A line graph depicting the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers. The graph compares data for Sildenafil 100 mg versus placebo, with systolic blood pressure (mmHg) on the vertical axis and time post dose (hours) on the horizontal axis.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph illustrating mean standing systolic blood pressure changes over time (hours) postdose. The graph compares Doxazosin plus placebo versus Doxazosin plus Sildenafil 50 mg, with systolic blood pressure change (mmHg) on the y-axis and time on the x-axis.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing blood pressure changes over time (hours) after dosing. Two lines compare the effects of Doxazosin + Sildenafil 100 mg versus Doxazosin + Placebo, with the y-axis representing change in mmHg and the x-axis representing time after dosing from 0 to 8 hours.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph showing mean plasma concentrations of Sildenafil over time in healthy male volunteers. The x-axis represents time post dose in hours, and the y-axis shows plasma concentrations in ng/ml. The graph tracks concentration changes following administration of a commercial Sildenafil tablet.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Bar chart showing the percentage of patients reporting improved erections. It compares placebo and three doses of Sildenafil Tablets (25 mg, 50 mg, 100 mg). The percentages increase with dose, from 24% for placebo to 82% for 100 mg Sildenafil Tablets.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure of sildenafil, the active ingredient in Sildenafil Citrate 25 mg oral film-coated tablets by NuCare Pharmaceuticals, Inc. The diagram shows the molecular arrangement of atoms and bonds in the sildenafil molecule.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph depicting the change in EPP (mM/Ca) over time postdose (hours) comparing Doxazosin with Placebo versus Doxazosin with Sildenafil 25 mg. The graph shows two data series with distinct trends and measurement points across an 8-hour period.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the distribution of patients by baseline score from 0 to 5 on the x-axis and percentage of patients at endpoint on the y-axis. The chart includes multiple data series represented by different shades and patterns, but specific values and variable names beyond these details are not visible.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart showing the percentage of patients at endpoint, stratified by baseline score from 0 to 5. Multiple bars for each baseline score indicate different groups or categories, with a legend presenting five distinct patterns or labels corresponding to the bars. The y-axis represents the percentage of patients, ranging from 0 to 80.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.